Summit - Philadelphia, PA, United States
With over 6,000 rare diseases recognized by NIH, the market for orphan and ultra-orphan indications represents a major growth area for pharma and biotech companies. But low patient numbers combined with urgency of unmet medical needs can make standard clinical trial procedures unfeasible.
ExL Pharma’s “Rare Disease Collaboration Summit” gives you the tools you need to build lasting partnerships with patient advocacy groups in order to construct more flexible and patient-centric clinical trial protocols and accelerate the regulatory approval of your orphan drug.
This event hosts the formation of working-group relationships that harness the collective resources of industry and patient advocates, creating a working framework for shaping legislation and convincing regulators. Build best practice outputs that outlive the meeting!
Organization: ExL Pharma
Tue, Aug 12, 2014 - Wed, Aug 13, 2014
Sonesta Hotel Philadelphia
Philadelphia, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.